191 related articles for article (PubMed ID: 11362996)
41. 3TC approval may revive AZT's appeal.
Vazquez E
Posit Aware; 1996; 7(1):8-9. PubMed ID: 11363136
[TBL] [Abstract][Full Text] [Related]
42. Clinical experience with saquinavir.
Vella S
AIDS; 1995 Dec; 9 Suppl 2():S21-S25. PubMed ID: 8775803
[TBL] [Abstract][Full Text] [Related]
43. Boston, Galveston, Jackson County, Jefferson County, New York City, Portland--new saquinavir trial.
AIDS Treat News; 1995 Sep; (no 231):6. PubMed ID: 11362872
[TBL] [Abstract][Full Text] [Related]
44. Why the old saquinavir (Invirase) may be bad for your health.
Vazquez E
Posit Aware; 1997; 8(4):28-31. PubMed ID: 11364485
[TBL] [Abstract][Full Text] [Related]
45. Protease inhibitor update: treatment combination strategies.
Mascolini M
AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
[TBL] [Abstract][Full Text] [Related]
46. 3TC/AZT: just another combination.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
[TBL] [Abstract][Full Text] [Related]
47. Saquinavir plus ritonavir reduce viral load by 99.9 percent.
Vazquez E
Posit Aware; 1996; 7(6):8-9. PubMed ID: 11363983
[TBL] [Abstract][Full Text] [Related]
48. Lamivudine (3TC) approved for combination use with AZT.
James JS
AIDS Treat News; 1995 Dec; (no 236):1-5. PubMed ID: 11363049
[TBL] [Abstract][Full Text] [Related]
49. Saquinavir with grapefruit juice.
Posit Aware; 1996; 7(1):5. PubMed ID: 11363122
[TBL] [Abstract][Full Text] [Related]
50. [The combination of saquinavir and ddC ensures longer survival].
Hoof T
Dtsch Med Wochenschr; 1996 Sep; 121(37):A30. PubMed ID: 8925721
[No Abstract] [Full Text] [Related]
51. Protease inhibitors-at-a-glance.
Notes Undergr; 1996 Apr; (no 32):4-5. PubMed ID: 11363449
[TBL] [Abstract][Full Text] [Related]
52. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
53. Nelfinavir - major trial results at retroviruses conference.
AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240
[TBL] [Abstract][Full Text] [Related]
54. Soft gel saquinavir has high exposure.
AIDS Alert; 1997 Dec; 12(12):143-4. PubMed ID: 11364835
[TBL] [Abstract][Full Text] [Related]
55. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
56. Fourth protease inhibitor hits the market.
AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
[TBL] [Abstract][Full Text] [Related]
57. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
James JS
AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
[TBL] [Abstract][Full Text] [Related]
58. FDA approves nelfinavir. Food and Drug Administration.
GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
[TBL] [Abstract][Full Text] [Related]
59. Stanford study of saquinavir reveals low toxicities.
AIDS Patient Care; 1995 Dec; 9(6):304-5. PubMed ID: 11361442
[No Abstract] [Full Text] [Related]
60. Saquinavir (Roche protease inhibitor) at higher doses.
AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]